Myriad Will Seek FDA Approval of BRACAnalysis CDx as a Companion Diagnostic for Olaparib
Trial results confirm the potential benefits of using biomarkers to guide care for men with metastatic castration-resistant prostate cancer.
Read MorePosted by Steve Halasey | Sep 17, 2019 | Prostate |
Trial results confirm the potential benefits of using biomarkers to guide care for men with metastatic castration-resistant prostate cancer.
Read MorePosted by Steve Halasey | Sep 11, 2019 | Dementias & Alzheimer’s, Diagnostic Technologies |
The US Preventive Services Task Force has issued two draft recommendation statements on screening for hepatitis C and for cognitive impairment.
Read MorePosted by Steve Halasey | Sep 9, 2019 | Flu & Respiratory Infections, Molecular Diagnostics, POC Reagents & Test Kits, Swabs |
Both the Accula Flu A/Flu B and RSV tests are approved for use with nasal swab collection, which is less invasive than nasopharyngeal swabs.
Read MorePosted by Steve Halasey | Sep 9, 2019 | Cancer, Pancreatic |
The partnership will focus on analysis of the circulating proteome of advanced pancreatic cancer patients, using the Biodesix Diagnostic Cortex machine-learning platform.
Read MorePosted by Steve Halasey | Sep 9, 2019 | Molecular Diagnostics |
Operators can load patient samples in a continuous, random-access workflow for sample processing, with a walkaway window of up to 8 hours.
Read More